Anti-IGF-1R human monoclonal antibody formulation

Details for Australian Patent Application No. 2007229554 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Pappenberger, Astrid; Stauch, Oliver Boris; Stracke, Jan Olaf; Grossmann, Adelbert; Mahler, Hanns-Christian

Agent Davies Collison Cave

Pub. Number AU-A-2007229554

PCT Pub. Number WO2007/110339

Priority 06111848.5 28.03.06 EP

Filing date 19 March 2007

Wipo publication date 4 October 2007

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

9 October 2008 PCT application entered the National Phase

  PCT publication WO2007/110339 Priority application(s): WO2007/110339

29 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007229555-Pyrimidine, quinazoline, pteridine and triazine derivatives

2007229552-Pyridine and pyrimidine derivatives as mGluR2 antagonists